DEO vs PLRX · P/E 16, $55.86B cap vs $77.3M cap
Diageo PLC ADR (DEO) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
DEO does not have a complete income-statement cache yet.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the DEO and PLRX stock pages for the full models.
Not investment advice.